eMedicine Specialties > Rheumatology > Infectious Arthritis

Nongonococcal Infectious Arthritis

Author: Edward Dwyer, MD, Department of Medicine, Assistant Professor, Columbia University College of Physicians and Surgeons
Contributor Information and Disclosures

Updated: Nov 26, 2007

Introduction

Background

Nongonococcal infectious arthritis is an acute or subacute illness with potentially significant morbidity and mortality. Bacteria, mycobacteria, and fungi can cause the disease. Both healthy individuals and individuals with predisposing conditions can be infected. Nongonococcal infectious arthritis is typically a monoarticular disease, but, in approximately 10% of patients, it affects multiple joints. Without treatment, the condition results in joint destruction.

Pathophysiology

Infectious arthritis ensues when foreign organisms invade the synovium or joint space. These organisms invade the joint via (1) hematogenous dissemination from a distant site; (2) periarticular infection, such as osteomyelitis or adjacent soft-tissue infection; or (3) direct introduction through penetrating trauma or procedural intervention, such as arthrocentesis or surgical repair.

Frequency

United States

The yearly incidence of bacterial arthritis varies from 2-10 cases per 100,000 persons in the general population to 30-70 cases per 100,000 persons in patients with rheumatoid arthritis.

Mortality/Morbidity

  • Mortality occurs in 10-15% of cases.
  • Joint destruction occurs in 25-50% of cases.

Race

  • No inherent racial predilections for infectious arthritis are recognized.

Sex

  • Sex is not an independent risk factor to predispose individuals to infectious arthritis.

Age

  • Age older than 80 years has been shown in some studies to be an independent risk factor for susceptibility to bacterial arthritis.

Clinical

History

  • The clinical course of bacterial arthritis is typically acute in onset.
    • Patients with joint prostheses are the exception. These patients' symptoms may persist for weeks or months before a diagnosis is made.
    • Individuals with mycobacterial or fungal arthritis also tend to have a much more indolent or subacute prodrome before the diagnosis is considered.
    • The sternoclavicular and sacroiliac joints are preferentially involved in patients who abuse parenteral drugs.
  • Joint pain, swelling, erythema, and loss of motion are common presenting symptoms.
    • The most commonly affected joint in persons with bacterial arthritis is the knee.
    • The shoulder, hip, elbow, and wrist joints are infected less frequently.
  • Approximately 10% of individuals with bacterial arthritis have infection in multiple joints, particularly in the presence of a preexisting destructive joint disease (eg, rheumatoid arthritis) or compromising medical conditions (eg, diabetes, glucocorticoid therapy).

Physical

  • During the first 24 hours of hospitalization, 78% of patients with nongonococcal bacterial arthritis exhibit fever; however, the fever rarely exceeds 39°C (102.2°F).
  • The patient may have decreased range of motion in the joint.
  • Swelling, tenderness to palpation, erythema, warmth to touch, and pain upon movement of the affected joint are common physical examination findings.

Causes

  • Risk factors
    • The presence of a preexisting, chronic, inflammatory, destructive arthritis, especially rheumatoid arthritis, is correlated with infectious arthritis. The recent introduction of anti–tumor necrosis factor (TNF) agents in the treatment of inflammatory arthritis may additionally predispose this population to infectious arthritis.
    • A person undergoing immunosuppressive therapy, such as with corticosteroids or cytotoxic agents, is more likely to become infected.
    • A person who has a prosthetic joint has greater risk of infection.
    • Elderly individuals are particularly at risk for infectious arthritis.
    • Comorbid nonarticular conditions, such as diabetes mellitus, immunodeficiency diseases, cancer, or intravenous drug abuse, also increase the risk of infectious arthritis.
  • Bacteria
    • Gram-positive cocci, especially Staphylococcus aureus, are the predominant etiologic agents. Streptococcal species are also common, especially group A streptococci.
    • If a prosthetic joint was implanted within the preceding 6 months, Staphylococcus epidermidis and S aureus are major pathogens.
    • Gram-negative bacilli are more common in elderly patients with chronic medical conditions.
    • Pseudomonas aeruginosa and methicillin-resistant S aureus are more prevalent in the infectious arthritis that affects individuals who abuse intravenous drugs.
    • Salmonella species exhibit a predilection for individuals with systemic lupus erythematosus.
    • Consider Pasteurella multocida subsequent to a cat bite or Eikenella corrodens after a human bite.
  • Mycobacteria
    • In addition to the common pathogen Mycobacterium tuberculosis, nontuberculous species, such as Mycobacterium kansasii, may spread from a pulmonary focus and infect a joint.
    • Mycobacterium marinum should be considered in individuals exposed to aquatic or marine environments.
  • Fungi
    • Candida organisms, including Candida albicans and Candida parapsilosis, are causative in debilitated hospitalized patients or in patients on long-term antibacterial therapy.
    • Sporothrix schenckii may infect the hand or wrist joints of a person frequently exposed to moist soil, rose thorns, or the outdoors.

More on Nongonococcal Infectious Arthritis

Overview: Nongonococcal Infectious Arthritis
Differential Diagnoses & Workup: Nongonococcal Infectious Arthritis
Treatment & Medication: Nongonococcal Infectious Arthritis
Follow-up: Nongonococcal Infectious Arthritis
References

References

  1. Chambers HF. Community-associated MRSA--resistance and virulence converge. N Engl J Med. Apr 7 2005;352(14):1485-7. [Medline].

  2. Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med. Mar 21 1985;312(12):764-71. [Medline].

  3. Harrington JT. Mycobacterial and fungal arthritis. Curr Opin Rheumatol. Jul 1998;10(4):335-8. [Medline].

  4. Kaandorp CJ, Krijnen P, Moens HJ, Habbema JD, van Schaardenburg D. The outcome of bacterial arthritis: a prospective community-based study. Arthritis Rheum. May 1997;40(5):884-92. [Medline].

  5. Mathews CJ, Kingsley G, Field M, Jones A, Weston VC, Phillips M, et al. Management of septic arthritis: a systematic review. Ann Rheum Dis. Apr 2007;66(4):440-5. [Medline].

  6. Shirtliff ME, Mader JT. Acute septic arthritis. Clin Microbiol Rev. Oct 2002;15(4):527-44. [Medline].

  7. Smith JW, Chalupa P, Shabaz Hasan M. Infectious arthritis: clinical features, laboratory findings and treatment. Clin Microbiol Infect. Apr 2006;12(4):309-14. [Medline].

  8. von Essen R. Culture of joint specimens in bacterial arthritis. Impact of blood culture bottle utilization. Scand J Rheumatol. 1997;26(4):293-300. [Medline].

Further Reading

Keywords

bacterial arthritis, fungal arthritis, candidal arthritis, mycobacterial arthritis, septic arthritis, infectious arthritis, non-gonococcal arthritis, nongonococcal infectious arthritis, non-gonococcal infectious arthritis, infected joint prosthesis, joint prosthesis infection, gram-positive cocci, Staphylococcus aureus, S aureus, Pseudomonas aeruginosa, P aeruginosa, Streptococcus, Staphylococcus epidermidis, S epidermidis, Salmonella, Pasteurella multocida, P multocida, Eikenella corrodens, E corrodens, Mycobacterium tuberculosis, M tuberculosis, Mycobacterium kansasii, M kansasii, Mycobacterium marinum, M marinum, Candida albicans, C albicans, Candida parapsilosis, C parapsilosis, Sporothrix schenckii, S schenckii, streptococcal species, group A streptococci, group A Streptococcus, methicillin-resistant S aureus, MRSA, candidal organisms, staphylococcal joint infections, staphylococcal arthritis

Contributor Information and Disclosures

Author

Edward Dwyer, MD, Department of Medicine, Assistant Professor, Columbia University College of Physicians and Surgeons
Edward Dwyer, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Rheumatology, and International Society for Heart and Lung Transplantation
Disclosure: Nothing to disclose.

Medical Editor

Robert E Wolf, MD, PhD, Professor Emeritus, Department of Medicine, Louisiana State University Health Sciences Center at Shreveport; Chief, Rheumatology Section, Medical Service, Overton Brooks Veterans Administration Medical Center of Shreveport
Robert E Wolf, MD, PhD is a member of the following medical societies: American College of Rheumatology, Arthritis Foundation, and Society for Leukocyte Biology
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Elliot Goldberg, MD, Dean of the Western Pennsylvania Clinical Campus, Professor, Department of Medicine, Temple University School of Medicine
Elliot Goldberg, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, and American College of Rheumatology
Disclosure: Nothing to disclose.

CME Editor

Alex J Mechaber, MD, FACP, Assistant Dean for Medical Curriculum, Associate Professor of Medicine, Division of General Internal Medicine, University of Miami Miller School of Medicine
Alex J Mechaber, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, and Society of General Internal Medicine
Disclosure: Nothing to disclose.

Chief Editor

Herbert S Diamond, MD, Professor of Medicine, Temple University School of Medicine; Chairman Emeritus, Department of Internal Medicine, Western Pennsylvania Hospital
Herbert S Diamond, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American College of Rheumatology, American Medical Association, and Phi Beta Kappa
Disclosure: medifocus Honoraria Review panel membership; health dialogs Honoraria Consulting; Merck, Amgen, Wyeth, Johnson&Johnson, Stryker, Medtronic, Zimmer.Abbott,  Ownership interest Other; West Penn Allegheny Health System Salary Employment; Pfizer Honoraria Consulting; Proctor&Gamble, Amgen, Pfizer Grant/research funds Independent contractor

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.